Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seungjoon Oh

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Diabetes & Metabolism Journal|May 4, 2011
Autoimmune hypoglycemia in a patient with characterization of insulin receptor autoantibodiesSuk Chon, Moon Chan Choi, Yun Jung Lee, et al.
Korean Diabetes Journal|July 10, 2010
The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjectsSang Youl Rhee, Joo Young Kim, Suk Chon, et al.
Endocrinology and Metabolism (Seoul, Korea)|October 14, 2014
Insufficient experience in thyroid fine-needle aspiration leads to misdiagnosis of thyroid cancerJung Il Son, Sang Youl Rhee, Jeong-Taek Woo, et al.
Diabetes Research and Clinical Practice|July 13, 2007
Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patientsMi-Kwang Kwon, Sang Youl Rhee, Suk Chon, et al.
Plos One|March 28, 2013
Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009Sang Ouk Chin, Sang Youl Rhee, Suk Chon, et al.
Diabetes & Metabolism Journal|November 8, 2013
Risk factors for the progression of intima-media thickness of carotid arteries: a 2-year follow-up study in patients with newly diagnosed type 2 diabetesSang Ouk Chin, Jin Kyung Hwang, Sang Youl Rhee, et al.
Diabetes, Obesity & Metabolism|March 5, 2023
Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, placebo-controlled, phase III trialSoo Heon Kwak, Kyung Ah Han, Kyung-Soo Kim, et al.
Diabetes, Obesity & Metabolism|April 5, 2023
Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12-week, multicentre, randomized, double-blind, placebo-controlled, phase 2 trialYe Seul Yang, Kyung Wan Min, Seok-O Park, et al.
Diabetes, Obesity & Metabolism|March 1, 2024
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozinSoo Lim, Seung-Hwan Lee, Kyung-Wan Min, et al.
Diabetes, Obesity & Metabolism|July 26, 2024
Long-term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52-week extension of a Phase 3 randomized controlled trialSoo Heon Kwak, Kyung Ah Han, Eun Sook Kim, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Diabetes & Metabolism Journal|May 4, 2011
Autoimmune hypoglycemia in a patient with characterization of insulin receptor autoantibodiesSuk Chon, Moon Chan Choi, Yun Jung Lee, et al.
Korean Diabetes Journal|July 10, 2010
The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjectsSang Youl Rhee, Joo Young Kim, Suk Chon, et al.
Endocrinology and Metabolism (Seoul, Korea)|October 14, 2014
Insufficient experience in thyroid fine-needle aspiration leads to misdiagnosis of thyroid cancerJung Il Son, Sang Youl Rhee, Jeong-Taek Woo, et al.
Diabetes Research and Clinical Practice|July 13, 2007
Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patientsMi-Kwang Kwon, Sang Youl Rhee, Suk Chon, et al.
Plos One|March 28, 2013
Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009Sang Ouk Chin, Sang Youl Rhee, Suk Chon, et al.
Diabetes & Metabolism Journal|November 8, 2013
Risk factors for the progression of intima-media thickness of carotid arteries: a 2-year follow-up study in patients with newly diagnosed type 2 diabetesSang Ouk Chin, Jin Kyung Hwang, Sang Youl Rhee, et al.
Diabetes, Obesity & Metabolism|March 5, 2023
Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, placebo-controlled, phase III trialSoo Heon Kwak, Kyung Ah Han, Kyung-Soo Kim, et al.
Diabetes, Obesity & Metabolism|April 5, 2023
Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12-week, multicentre, randomized, double-blind, placebo-controlled, phase 2 trialYe Seul Yang, Kyung Wan Min, Seok-O Park, et al.
Diabetes, Obesity & Metabolism|March 1, 2024
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozinSoo Lim, Seung-Hwan Lee, Kyung-Wan Min, et al.
Diabetes, Obesity & Metabolism|July 26, 2024
Long-term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52-week extension of a Phase 3 randomized controlled trialSoo Heon Kwak, Kyung Ah Han, Eun Sook Kim, et al.
Pageof 6